EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes

Edgar Bernardo, Matías Gonzalo De Vas, Diego Balboa, Mirabai Cuenca-Ardura, Sílvia Bonàs-Guarch, Mercè Planas-Fèlix, Fanny Mollandin, Miquel Torrens-Dinarès, Miguel Angel Maestro, Javier García-Hurtado, Sonia Moratinos, Philippe Ravassard und 10 weitere

Cell Metabolism · 2025-09 · 37 (9) · 1870-1889.e10

DOI: 10.1016/j.cmet.2025.07.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2025-09. Verfasst von Edgar Bernardo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genomic Regulation, the Barcelona Institute of Science and Technology, Barcelona, Spain; Centro de Investigación Biomédica en Red Diabetes…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hepatocyte Nuclear Factor 1-alpha, Insulin-Secreting Cells, Transcription, Genetic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, European Molecular Biology Organization, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a devastating chronic disease marked by pancreatic β cell dysfunction and insulin resistance, whose pathophysiology remains poorly understood. HNF1A, which encodes transcription factor hepatocyte nuclear factor-1 alpha, is the most commonly mutated gene in Mendelian diabetes. HNF1A also carries loss- or gain-of-function coding variants that respectively predispose to or protect against polygenic T2D. The mechanisms underlying HNF1A-deficient diabetes, however, are still unclear. We now demonstrate that diabetes arises from β cell-autonomous defects and identify direct β cell genomic targets of HNF1A. This uncovered a regulatory axis where HNF1A controls transcription of A1CF, which orchestrates an RNA splicing program encompassing genes that regulate β cell function. This HNF1A-A1CF transcription-splicing axis is suppressed in β cells from T2D individuals, while genetic variants reducing pancreatic islet A1CF are associated with increased glycemia and T2D susceptibility. Our findings, therefore, identify a linear hierarchy that coordinates β cell-specific transcription and splicing programs and link this pathway to T2D pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hepatocyte Nuclear Factor 1-alphaInsulin-Secreting CellsTranscription, GeneticRNA SplicingHumansAnimalsMiceMaleMice, Inbred C57BL

Stichwörter der Autor:innen

HNF1 homeobox AHNF1AMODY-3RNA splicinggene regulatory networksgene transcriptiongenetics of diabeteshuman embryonic stem cell-derived isletshuman geneticspancreatic beta cellspancreatic isletssplicing factor networkstype 2 diabetes

Substanzen

Hepatocyte Nuclear Factor 1-alphaHNF1A protein, human

Autor:innen und Institutionen

  • Centre for Genomic Regulation, the Barcelona Institute of Science and Technology, Barcelona, Spain; Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
  • Section of Genetics and Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Centre for Genomic Regulation, the Barcelona Institute of Science and Technology, Barcelona, Spain; Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain; Se…
  • Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France.
  • Department of Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.

Förderung

  • European Research Council
  • European Molecular Biology Organization
  • UK Research and Innovation Medical Research Council
  • Vanderbilt University
  • Generalitat de Catalunya
  • Boehringer Ingelheim Fonds
  • National Institute on Handicapped Research
  • H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

Bernardo, E., De Vas, M. G., Balboa, D., Cuenca-Ardura, M., Bonàs-Guarch, S., Planas-Fèlix, M., Mollandin, F., Torrens-Dinarès, M., Maestro, M. A., García-Hurtado, J., Moratinos, S., Ravassard, P., Dou, H., Heyn, H., van Oudenaarden, A., Groen, N., de Koning, E., Conrad, C., Eils, R., …, & Ferrer, J. (2025). HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes. Cell Metabolism, 37(9), 1870-1889.e10. https://doi.org/10.1016/j.cmet.2025.07.007

Vancouver

Bernardo E, De Vas MG, Balboa D, Cuenca-Ardura M, Bonàs-Guarch S, Planas-Fèlix M, et al. HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes. Cell Metabolism. 2025;37(9):1870-1889.e10. doi:10.1016/j.cmet.2025.07.007

BibTeX
@article{Bernardo2025,
  author = {Bernardo, Edgar and De Vas, Matías Gonzalo and Balboa, Diego and Cuenca-Ardura, Mirabai and Bonàs-Guarch, Sílvia and Planas-Fèlix, Mercè and Mollandin, Fanny and Torrens-Dinarès, Miquel and Maestro, Miguel Angel and García-Hurtado, Javier and Moratinos, Sonia and Ravassard, Philippe and Dou, Haiqiang and Heyn, Holger and van Oudenaarden, Alexander and Groen, Nathalie and de Koning, Eelco and Conrad, Christian and Eils, Roland and Vernia, Santiago and Rorsman, Patrik and Ferrer, Jorge},
  title = {HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes},
  journal = {Cell Metabolism},
  year = {2025},
  volume = {37},
  number = {9},
  pages = {1870--1889.e10},
  doi = {10.1016/j.cmet.2025.07.007}
}
Kostenlos starten →